SCHEMBL3380210

SCHEMBL3380210

CCCCS(=O)(=O)Nc1ccc(OS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.53
ENPP1 P22413 4/20 0.52
HPGD P15428 2/20 0.49
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
ENPP2 Q13822 4/20 0.47
ENPP3 O14638 3/20 0.47
LMNA P02545 1/20 0.47
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA4 P22748 2/20 0.44
CA7 P43166 2/20 0.44
CA9 Q16790 2/20 0.44
FFAR1 O14842 1/20 0.43
PPARG P37231 1/20 0.43
MRGPRX1 Q96LB2 1/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10192137 0.84 HPGD (0.60) ARHPGDKDM4EALDH1A1GAA
SCHEMBL14401514 0.82 ENPP1 (0.48) ENPP1ALDH1A1MAPTENPP2ENPP3
SCHEMBL22187208 0.79 ENPP1 (0.58) ENPP1KDM4EALDH1A1MAPTENPP2
SCHEMBL3381347 0.79 ENPP2 (0.54) ENPP1ALDH1A1GAAMAPTENPP2
SCHEMBL9453329 0.78 HPGD (0.56) ARHPGDKDM4EALDH1A1GAA
SCHEMBL11066198 0.78 HPGD (0.56) ARHPGDKDM4EALDH1A1GAA
SCHEMBL13763467 0.78 HPGD (0.56) ARHPGDKDM4EALDH1A1GAA
SCHEMBL26277471 0.78 HPGD (0.56) ARHPGDKDM4EALDH1A1GAA
SCHEMBL17993333 0.76 ENPP1 (0.60) ENPP1ALDH1A1MAPTLMNACA12
SCHEMBL4126086 0.76 MEN1 (0.60) ENPP1HPGDALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160304-A1 AROMATIC SULFONE COMPOUND AS ALDOSTERONE RECEPTOR MODULATOR DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2010-06-24 US disclosed
US-20100160304-A1 AROMATIC SULFONE COMPOUND AS ALDOSTERONE RECEPTOR MODULATOR DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2010-06-24 US disclosed
US-20100160304-A1 AROMATIC SULFONE COMPOUND AS ALDOSTERONE RECEPTOR MODULATOR DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2010-06-24 US disclosed
EP-1844768-A1 AROMATIC SULFONE COMPOUND AS ALDOSTERONE RECEPTOR MODULATOR Dainippon Sumitomo Pharma Co., Ltd. (JP) 2007-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160304-A1 AROMATIC SULFONE COMPOUND AS ALDOSTERONE RECEPTOR MODULATOR NR3C2, AGTR1, AGTR2 AR 17/4885ENPP1 3930/4885HPGD 2076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.